Page 1

APRIA Apria Announces Financial Results for Second Quarter 2021 August 5 , 2021 INDIANAPOLIS , Aug. 05 , 2021 ( GLOBE NEWSWIRE ) -- Apria , Inc. ( the " Company " or " Apria " ) ( Nasdaq : APR ) , a leading provider of integrated home healthcare equipment and related services in the United States , announced today financial results for the second quarter ended June 30 , 2021 . " We delivered another strong quarter as our second quarter 2021 financial results were ahead of our expectations on all three of our key metrics , achieving organic net revenue growth of over 6.0 % as compared to the prior year quarter , " said Dan Starck , CEO of Apria . " On July 30 , we signed a definitive agreement to acquire Airway Breathing Co. , a provider of respiratory care services , sleep equipment and supplies , and durable medical equipment . This acquisition enhances our presence in some attractive markets in Virginia and strengthens our relationships with the local health care systems . We continue to have a robust active pipeline and we expect to see more strategic M & A opportunities throughout the remainder of the year . " Mr. Starck continued , " As most of you are aware , in mid - June , Philips / Respironics issued a product recall for a large portion of their CPAPs , BiPaps and ventilators . The recall has created significant disruption in the industry , and when coupled with the component shortages being experienced by other manufacturers , the availability of equipment to support newly diagnosed sleep and ventilation patients may be limited . The Apria team has done an excellent job managing the complexities of the recall , and our entire organization continues to execute at a high level to help deliver the highest quality of care and service to our patients which positions us well to drive future growth . " Second Quarter Financial Highlights Comparisons are to the three months ended June 30 , 2020 . • Net revenue of $ 286.3 million , up 6.4 % compared to $ 268.9 million • Net Income of $ 20.6 million , or $ 0.54 per diluted share , up 153.1 % from $ 8.1 million • Adjusted EBITDA of $ 64.4 million , up 15.5 % compared to $ 55.7 million • Adjusted EBITDA less Patient Equipment Capex of $ 44.1 million , up 2.2 % from $ 43.1 million 2021 Financial Guidance For the third quarter of 2021 , Apria is currently projecting the following financial results : • Net revenue of $ 282 million to $ 290 million • Adjusted EBITDA of $ 57 million to $ 61 million • Adjusted EBITDA less Patient Equipment Capex of $ 35 million to $ 38 million For the full year 2021 , Apria is increasing guidance and is now projecting the following financial results : • Net revenue of $ 1.12 billion to $ 1.15 billion ; up from $ 1.12 billion to $ 1.14 billion • Adjusted EBITDA of $ 221 million to $ 231 million ; up from $ 207 million to $ 216 million • Adjusted EBITDA less Patient Equipment Capex of $ 132 million to $ 142 million ; up from $ 113 million to $ 120 million Conference Call Apria will host a conference call to discuss second quarter 2021 results on August 5 , 2021 at 5:00 p.m. Eastern Time . The conference call can be accessed by dialing ( 833 ) 362-0207 for U.S. participants or ( 914 ) 987-7676 for international participants , and referencing conference ID 5380517 ; or via a live audio webcast that will be available online at https://ir.apria.com/ . A replay of the call will be available via webcast for on - demand listening shortly after the completion of the call , at the same web link , and will remain available for approximately 90 days . About Apria Apria is a leading provider of integrated home healthcare equipment and related services in the United States . The Company offers a comprehensive range of products and services for in - home care and delivery across three core service lines : ( 1 ) home respiratory therapy ( including home oxygen and non - invasive ventilation ( " NIV " ) services ) ; ( 2 ) obstructive sleep apnea ( " OSA " ) treatment ( including continuous positive airway pressure ( " CPAP " ) and bi - level positive airway pressure devices , and patient support services ) ; and ( 3 ) negative pressure wound therapy ( " NPWT " ) . Additionally , the Company supplies a wide range of home medical equipment and other products and services to help improve the quality of life for patients with home care needs . Our revenues are generated through fee - for - service and capitation arrangements with third - party healthcare payors , including